Published in
American Society for Microbiology, Microbiology Spectrum, 2023
DOI: 10.1128/spectrum.00333-23
Links
Tools
Molecular Characterization of AZD7442 (Tixagevimab-Cilgavimab) Neutralization of SARS-CoV-2 Omicron Subvariants
Journal article published in 2023 by
Tiffany L. Roe 
,
Tyler Brady,
Nicolette Schuko,
Amy Nguyen,
Jagadish Beloor,
Johnathan D. Guest ,
Anastasia A. Aksyuk ,
Kevin M. Tuffy,
Tianhui Zhang ,
Katie Streicher ,
Elizabeth J. Kelly ,
Gustavo H. Kijak
,
Tyler Brady,
Nicolette Schuko,
Amy Nguyen,
Jagadish Beloor,
Johnathan D. Guest ,
Anastasia A. Aksyuk ,
Kevin M. Tuffy,
Tianhui Zhang ,
Katie Streicher ,
Elizabeth J. Kelly ,
Gustavo H. Kijak
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
MAbs are key therapeutic options for COVID-19 prophylaxis and treatment in immunosuppressed and vulnerable populations. Due to the emergence of SARS-CoV-2 variants, including Omicron, it is vital to ensure that neutralization is maintained for MAb-based interventions.